At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,032 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study
In Brief
An observational study for Cancer. Completed, enrolled 3,032 participants across 27 sites.
Detailed Summary
The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedJan 2014
Primary CompletionMar 2015
TodayJul 2026
First PostedJan 1, 2014
Enrollment StartJun 1, 2010
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 12.5 years ago